CDI Labs
Baltimore, MD, United States cdilabs.com From their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
CDI Labs is a specialized CRO and lab services company focused on proteomics, autoantibody profiling, biomarker discovery, target identification, and related antibody specificity work. It serves academic and industry customers from sites in Mayagüez, Puerto Rico and Baltimore, Maryland, with operations also listed in Toronto, Canada. The company supports research across autoimmune disease, oncology, neurological disease, infectious disease, and genetic disease.
Services
HuProt™ Services
Uses a human proteome microarray with 21,000+ full-length proteins for autoantibody profiling and target ID.
VirScan® PhIP-Seq Services
Profiles antibodies against known vertebrate viral proteomes using phage display immunoprecipitation sequencing.
VirScan® Exposome PhIP-Seq Services
Profiles antibody responses against non-human allergen and other exposome protein sequences.
HuScan® PhIP-Seq Services
Performs epitope-level autoantibody profiling against the human proteome with quantitative sequencing readouts.
MouseScan™ PhIP-Seq Services
Performs epitope-level autoantibody profiling against the murine proteome for preclinical samples.
Peptide Hormone Services
Offers peptide hormone-related services as part of the service platform lineup.
Pan-isotype Profiling Services
Profiles antibody responses across isotypes.
Molecular Glue Discovery
Supports discovery of ternary complex interactions using the HuGlue® technology access program.
12 more services
- Custom PhIP-Seq Libraries
- Biomarker Discovery
- Patient Stratification
- Patient Response / Adverse Reaction Prediction
- Diagnostic Development
- Vaccine Development and Safety
- Viral Exposure Profiling
- Target ID Services
- Antibody Development
- Antibody Pairs
- Protein Production
- Immunogenicity Testing
- What to send
- Peripheral serum
- Plasma
- Cerebrospinal fluid
- Tissue lysates
- Stool
- Saliva
- Synthesized sample
- Preclinical murine samples
Capabilities
- Assays and studies
- Antibodies
- Peptides
- Immunogenicity
- Phage display
- CRISPR
- Cell therapy
16 more
- Small molecules
- Rodent models
- Autoantibody profiling
- Biomarker discovery
- Target identification
- Target deconvolution
- Protein-protein interaction profiling
- Protein-nucleic acid interaction profiling
- Antibody specificity validation
- Post-translational modification specificity testing
- Viral exposure profiling
- Immunogenicity testing
- Pan-isotype profiling
- Epitope-level profiling
- PhIP-Seq
- Microarray profiling
- Scale and capacity
- 21,000+ full-length human proteins
- 48,921 human proteins and isoforms
- 68,000+ viral protein sequences
- 15,860+ non-human allergen protein sequences
- 50,135 murine proteins and protein isoforms
- 200,000+ compounds per screen
- Therapeutic areas
- Autoimmune disease
- Oncology
- Neurological disease
- Infectious disease
- Genetic disease
Instruments and platforms
- HuProt™ microarray
- HuScan® PhIP-Seq
- VirScan® PhIP-Seq
- MouseScan™ PhIP-Seq
- Fluorescence intensity measurements
- Illumina sequencing
Modalities and species
- Modalities
- Small molecule
- Antibody
- ADC
- Peptide
- Oligonucleotide
- Cell therapy
3 more
- Gene editing
- Recombinant protein
- Vaccine
- Species and models
- Human
- Mouse
- Murine
- E. coli
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
GLPSelf-reported
Details
- Type
- CRO
- Based in
- Baltimore, MD, United States
- Sites
- Mayagüez, Puerto Rico
- Toronto, Canada
- Serves
- Canada, Europe, Japan, China, United Kingdom